3,705 Shares in Chemed Corporation $CHE Acquired by Quantbot Technologies LP

Quantbot Technologies LP purchased a new position in shares of Chemed Corporation (NYSE:CHE) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 3,705 shares of the company’s stock, valued at approximately $1,726,000.

A number of other hedge funds also recently made changes to their positions in the stock. Monetary Solutions Ltd purchased a new stake in Chemed during the fourth quarter valued at about $25,000. Los Angeles Capital Management LLC purchased a new position in Chemed in the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the fourth quarter valued at approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Chemed during the second quarter valued at approximately $34,000. Finally, Versant Capital Management Inc lifted its position in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after buying an additional 75 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Down 0.1%

NYSE:CHE opened at $540.18 on Tuesday. The company has a market capitalization of $7.06 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. Chemed Corporation has a one year low of $365.20 and a one year high of $557.00. The stock has a 50-day simple moving average of $501.57 and a 200 day simple moving average of $447.26. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same quarter in the prior year, the firm posted $4.27 earnings per share. Chemed’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Sell-side analysts predict that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s dividend payout ratio is currently 14.06%.

Insider Transactions at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Spencer S. Lee sold 1,000 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total transaction of $541,040.00. Following the sale, the executive vice president directly owned 13,912 shares in the company, valued at $7,526,948.48. This trade represents a 6.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Royal Bank Of Canada lifted their target price on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Oppenheimer upped their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Finally, Bank of America reiterated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.